Inventor
YANG ZHI-YONG
US36 patents
⚠️ This page may combine multiple inventors who share the name “YANG ZHI-YONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
9 patentsUS7094598B2Aug 22, 2006
Development of a preventive vaccine for filovirus infection in primates
US HEALTH43 citations96
US7947822B2May 24, 2011
HIV vaccines based on Env of multiple clades of HIV
US HEALTH17 citations92
US10035844B2Jul 31, 2018
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH6 citations83
US9695230B2Jul 4, 2017
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH9 citations83
US7635688B2Dec 22, 2009
Development of a preventive vaccine for filovirus infection in primates
US HEALTH6 citations73
US10035845B2Jul 31, 2018
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US9738703B2Aug 22, 2017
Neutralizing antibodies to HIV-1 and their use
US HEALTH2 citations72
US10815295B2Oct 27, 2020
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH0 citations51
US7666427B2Feb 23, 2010
HIV vaccines based on Env of multiple clades of HIV
US HEALTH0 citations51
SANOFI SA
9 patentsUS10882922B2Jan 5, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA20 citations93
US11530268B2Dec 20, 2022
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection
SANOFI SA15 citations84
US11186649B2Nov 30, 2021
Anti-CD38 antibodies and methods of use
SANOFI SA10 citations84
US11192960B2Dec 7, 2021
Trispecific and/or trivalent binding proteins
SANOFI SA6 citations83
US11129905B2Sep 28, 2021
Bivalent, bispecific binding proteins for prevention or treatment of HIV infection
SANOFI SA6 citations83
US11779651B2Oct 10, 2023
Bivalent, bispecific binding proteins for prevention or treatment of HIV infection
SANOFI SA2 citations72
US11613576B2Mar 28, 2023
Trispecific binding proteins, methods, and uses thereof
SANOFI SA3 citations71
US12227573B2Feb 18, 2025
Trispecific binding proteins, methods, and uses thereof
SANOFI SA0 citations61
US11932704B2Mar 19, 2024
Trispecific and/or trivalent binding proteins
SANOFI SA0 citations51
UNIV MICHIGAN
6 patentsUS5863904AJan 26, 1999
Methods for treating cancers and restenosis with P21
UNIV MICHIGAN93 citations98
US6218372B1Apr 17, 2001
Methods for treating restenosis with p21
UNIV MICHIGAN70 citations96
US6057300AMay 2, 2000
Methods for treating cancers and restenosis with p21
UNIV MICHIGAN56 citations96
US6818016B1Nov 16, 2004
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
UNIV MICHIGAN10 citations74
US5650306AJul 22, 1997
Recombinant nucleic acids for inhibiting HIV gene expression
UNIV MICHIGAN11 citations71
US7087582B1Aug 8, 2006
Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21
UNIV MICHIGAN1 citations52
NABEL GARY J
5 patentsUS8454972B2Jun 4, 2013
Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen
NABEL GARY J212 citations98
US8106026B2Jan 31, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J11 citations92
US8323961B2Dec 4, 2012
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
NABEL GARY J13 citations90
US8124592B2Feb 28, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J3 citations73
US8106027B2Jan 31, 2012
Development of a preventive vaccine for filovirus infection in primates
NABEL GARY J3 citations73
MASCOLA JOHN R
2 patentsSULLIVAN NANCY
2 patentsUS9012618B2Apr 21, 2015
Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures
SULLIVAN NANCY5 citations81
US8101739B2Jan 24, 2012
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
SULLIVAN NANCY10 citations81